Snibe Co., Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd (briefed as Snibe) is a leading global in-vitro diagnostic biomedical company. Snibe has focused on the Chemiluminescent immunoassay (CLIA) field for more than 25 years. We are providing customized diagnostic solutions to laboratories in more than 145 countries and regions. Over 14000 units of Snibe's products have been installed in hospitals and labs worldwide, including global chain labs like Synlab, Eurofins, Cerba, Synevo, etc.

Snibe established 4 core R&D centers, including reagent, instrument, magnetic microbead, and reagent raw material to lay a solid foundation for developing the broadest range of CLIA analyzers and test menu. We successfully developed the fastest CLIA analyzer in the world - MAGLUMI X8 with the throughput of 600T/H in 2018. In order to meet the demand of mega-laboratories, Snibe announced a strategic partnership with Thermofisher and Hitachi to launch the Total Laboratory Automation solution in 2019. Moreover, to help the fight against COVID-19, Snibe successfully developed the 2019-nCoV (SARS-CoV-2) CLIA Kits in 2020, the first of its kind in the world to received CE mark.

Our Mission is "Creating value for human health through continuous innovation".